Patent assignee · US · COMPANY

Agios Pharmaceuticals, Inc.

🏢 View company profile →
96Patents
96Active
96Granted
57Portfolio score

Filing activity: Jun 29, 2010 → Nov 10, 2023 · 1 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8742119B2 Pyruvate kinase M2 modulators, therapeutic compositions and related methods of use Chemistry; Metallurgy 37 Active
US8785450B2 Therapeutic compounds and compositions Emerging Cross-Sectional Technologies 31 Active
US8889667B2 Therapeutic compounds and compositions Chemistry; Metallurgy 28 Active
US9474779B2 Therapeutically active compositions and their methods of use Chemistry; Metallurgy 26 Active
US9108921B2 Therapeutic compounds and compositions Chemistry; Metallurgy 21 Active
US9512107B2 Therapeutically active compositions and their methods of use Chemistry; Metallurgy 20 Active
US9328077B2 Bicyclic PKM2 activators Chemistry; Metallurgy 19 Active
US8501953B2 PKM2 modulators for use in the treatment of cancer Chemistry; Metallurgy 18 Active
US9850277B2 Therapeutically active compositions and their methods of use Chemistry; Metallurgy 17 Active
US9458132B2 Therapeutic compounds and compositions and their use as PKM2 modulators Chemistry; Metallurgy 17 Active
US8883438B2 Method for diagnosing cell proliferation disorders having a neoactive mutation at residue 97 of isocitrate dehydrogenase 1 Chemistry; Metallurgy 16 Active
US9221792B2 N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators Human Necessities 16 Active
US9181231B2 Pyruvate kinase activators for use for increasing lifetime of the red blood cells and treating anemia Chemistry; Metallurgy 15 Active
US9579324B2 Therapeutically active compounds and their methods of use Chemistry; Metallurgy 15 Active
US9968595B2 Pharmaceutical compositions of therapeutically active compounds Chemistry; Metallurgy 13 Active
US9193701B2 Pyruvate kinase activators for use in therapy Chemistry; Metallurgy 13 Active
US9732062B2 Therapeutically active compounds and their methods of use Chemistry; Metallurgy 11 Active
US9199968B2 Therapeutic compounds and compositions Chemistry; Metallurgy 11 Active
US9656999B2 Therapeutically active compounds and their methods of use Chemistry; Metallurgy 11 Active
US9404081B2 Pyruvate kinase activators for use in therapy Chemistry; Metallurgy 11 Active
US9682080B2 Pyruvate kinase activators for use in therapy Chemistry; Metallurgy 11 Active
US9738625B2 Therapeutically active compounds and their methods of use Chemistry; Metallurgy 11 Active
US9694013B2 Therapeutically active compounds and their methods of use Human Necessities 11 Active
US9724350B2 N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer Chemistry; Metallurgy 10 Active
US10610125B2 Methods and compositions for cell-proliferation-related disorders Emerging Cross-Sectional Technologies 9 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.